Inotiv Inc reports results for the quarter ended September 30 - Earnings Summary

Inotiv

03/12/2024 22:02

* Inotiv Inc  NOTV.OQ  reported a quarterly adjusted loss
of 73
cents​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of -38
cents.  The mean expectation of three analysts for the quarter
was for a loss of 91 cents per share. 
    * Revenue fell 7.3% to $130.42 million from a year ago;
analysts
expected $116.94 million. 
    * Inotiv Inc's reported EPS for the quarter was a loss of 73
cents​.
    * The company reported a quarterly loss of $18.89 million.
    * Inotiv Inc shares had risen by 129.4% this quarter and
gained 6.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inotiv Inc is
$4.00 
This summary was machine generated from LSEG data December 3 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.91          -0.73          Beat
 Jun. 30 2024      -0.83          -1.00          Missed
 Mar. 31 2024      -0.54          -1.86          Missed
 Dec. 31 2023      -0.85          -0.60          Beat